Lexaria Releases Additional Results from its Successful Phase 1b Study GLP-1-H24-4 Life Science Investing
BladeRanger to Showcase Advanced Green Energy Technologies at Abu Dhabi Sustainability Week Life Science Investing
NeoGenomics Appoints Diagnostics and Lab Services Industry Veteran John P. "Jack" Kenny to its Board of Directors Life Science Investing
Royalty Pharma Acquires Remaining Royalty Interest in Roche's Evrysdi for $240 Million and Potential Milestones Life Science Investing
Mereo BioPharma Announces Phase 3 ORBIT and COSMIC Results for Setrusumab in Osteogenesis Imperfecta Biotech Investing
neffy® Approved in China as the First and Only Community Use Epinephrine Product for the Treatment of Allergic Reactions Life Science Investing
Indaptus Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar Life Science Investing
Greenwich LifeSciences Extends Lock-up of Directors and Officers to September 30, 2026 Life Science Investing
